PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1505.0
(1.01%)
IDR 1505.0
(1.01%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 942.41 Billion IDR | -6.33% |
| 2022 | 1006.12 Billion IDR | 1.04% |
| 2021 | 995.76 Billion IDR | 6.84% |
| 2020 | 931.98 Billion IDR | -4.26% |
| 2019 | 973.48 Billion IDR | 5.19% |
| 2018 | 925.4 Billion IDR | 3.52% |
| 2017 | 893.95 Billion IDR | 11.54% |
| 2016 | 801.43 Billion IDR | 18.25% |
| 2015 | 677.73 Billion IDR | 15.81% |
| 2014 | 585.21 Billion IDR | -11.42% |
| 2013 | 660.65 Billion IDR | 1.47% |
| 2012 | 651.1 Billion IDR | 4.47% |
| 2011 | 623.27 Billion IDR | 6.06% |
| 2010 | 587.64 Billion IDR | 9.62% |
| 2009 | 536.07 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 284.64 Billion IDR | 4.03% |
| 2024 Q3 | 272.49 Billion IDR | -2.93% |
| 2024 Q2 | 280.71 Billion IDR | -1.38% |
| 2023 Q4 | 273.61 Billion IDR | 51.87% |
| 2023 FY | 942.41 Billion IDR | -6.33% |
| 2023 Q1 | 261.31 Billion IDR | 35.9% |
| 2023 Q2 | 246.77 Billion IDR | -5.56% |
| 2023 Q3 | 180.16 Billion IDR | -26.99% |
| 2022 Q4 | 192.28 Billion IDR | -14.15% |
| 2022 Q1 | 356.21 Billion IDR | 125.69% |
| 2022 Q2 | 233.63 Billion IDR | -34.41% |
| 2022 FY | 1006.12 Billion IDR | 1.04% |
| 2022 Q3 | 223.98 Billion IDR | -4.13% |
| 2021 Q4 | 157.83 Billion IDR | -52.57% |
| 2021 FY | 995.76 Billion IDR | 6.84% |
| 2021 Q1 | 259.14 Billion IDR | -4.83% |
| 2021 Q2 | 246.01 Billion IDR | -5.07% |
| 2021 Q3 | 332.77 Billion IDR | 35.27% |
| 2020 Q1 | 248.65 Billion IDR | 21.53% |
| 2020 Q4 | 272.28 Billion IDR | 59.92% |
| 2020 Q3 | 170.26 Billion IDR | -29.29% |
| 2020 FY | 931.98 Billion IDR | -4.26% |
| 2020 Q2 | 240.79 Billion IDR | -3.16% |
| 2019 Q3 | 264.38 Billion IDR | 16.34% |
| 2019 Q1 | 277.23 Billion IDR | 11.23% |
| 2019 Q2 | 227.25 Billion IDR | -18.03% |
| 2019 FY | 973.48 Billion IDR | 5.19% |
| 2019 Q4 | 204.6 Billion IDR | -22.61% |
| 2018 FY | 925.4 Billion IDR | 3.52% |
| 2018 Q4 | 249.24 Billion IDR | 12.22% |
| 2018 Q3 | 222.11 Billion IDR | 11.73% |
| 2018 Q2 | 198.78 Billion IDR | -22.12% |
| 2018 Q1 | 255.25 Billion IDR | 30.35% |
| 2017 Q2 | 219.84 Billion IDR | -11.36% |
| 2017 Q3 | 230.27 Billion IDR | 4.75% |
| 2017 Q1 | 248.01 Billion IDR | 27.2% |
| 2017 FY | 893.95 Billion IDR | 11.54% |
| 2017 Q4 | 195.82 Billion IDR | -14.96% |
| 2016 Q2 | 191.57 Billion IDR | -7.46% |
| 2016 Q4 | 194.97 Billion IDR | -6.2% |
| 2016 FY | 801.43 Billion IDR | 18.25% |
| 2016 Q1 | 207.01 Billion IDR | 20.92% |
| 2016 Q3 | 207.87 Billion IDR | 8.51% |
| 2015 Q3 | 162.95 Billion IDR | 1.33% |
| 2015 FY | 677.73 Billion IDR | 15.81% |
| 2015 Q1 | 182.75 Billion IDR | 20.86% |
| 2015 Q2 | 160.82 Billion IDR | -12.0% |
| 2015 Q4 | 171.19 Billion IDR | 5.05% |
| 2014 Q1 | 115.74 Billion IDR | -17.43% |
| 2014 FY | 585.21 Billion IDR | -11.42% |
| 2014 Q4 | 151.2 Billion IDR | -12.75% |
| 2014 Q3 | 173.31 Billion IDR | 19.57% |
| 2014 Q2 | 144.95 Billion IDR | 25.23% |
| 2013 Q3 | 143.61 Billion IDR | -27.25% |
| 2013 Q1 | 178.74 Billion IDR | 5.73% |
| 2013 FY | 660.65 Billion IDR | 1.47% |
| 2013 Q4 | 140.17 Billion IDR | -2.4% |
| 2013 Q2 | 197.4 Billion IDR | 10.44% |
| 2012 Q3 | 135.65 Billion IDR | 0.0% |
| 2012 FY | 651.1 Billion IDR | 4.47% |
| 2012 Q4 | 169.06 Billion IDR | 24.62% |
| 2011 FY | 623.27 Billion IDR | 6.06% |
| 2010 FY | 587.64 Billion IDR | 9.62% |
| 2009 FY | 536.07 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Merck Tbk | 391.72 Billion IDR | -140.579% |
| PT Phapros, Tbk | 533.85 Billion IDR | -76.53% |
| PT Pyridam Farma Tbk | 282.01 Billion IDR | -234.172% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 2018.69 Billion IDR | 53.316% |
| PT Tempo Scan Pacific Tbk | 4513.76 Billion IDR | 79.121% |